Vasilis Babaliaros, MD
Professor of Medicine and Surgery
Emory University School of Medicine
Co-Director, Transcatheter Valvular Interventions and Structural Heart Disease Therapies
Emory University Hospitals
- BS, Biomedical Engineering , Duke University, Durham, NC, 1992
- MD, Emory University School of Medicine, Atlanta, GA, 1996
- Residency and Fellowship, Internal Medicine and Cardiology, Emory University School of Medicine, Atlanta, GA, 2003
- Fellowship, Interventional Cardiology, Emory University School of Medicine, Atlanta, GA , 2003
- Sub-specialty Training, Valvular Interventional Cardiology, University of Rouen, Rouen, France, 2005
Dr. Babaliaros is Professor of Medicine and Surgery at Emory University. He received his Biomedical Engineering degree at Duke University (1992), his MD degree at Emory University (1996), and completed his training in Internal Medicine and Cardiology at Emory (2003). In 2004, he completed fellowship training in Interventional Cardiology at Emory University and then continued sub-specialty training in Valvular Interventional Cardiology under Alain Cribier MD at the University of Rouen, France (2005). He joined the faculty working with Peter Block MD as the Associate Director of the Emory Center for Valvular Intervention and Structural Heart Disease Treatment in 2006.
Dr. Babaliaros is clinically based out of Emory University Hospital in the Druid Hills area and Grady Memorial Hospital in downtown Atlanta.
Dr. Babaliaros teaches general cardiology and heart catheterization, but devotes most of his teaching efforts training future interventional cardiologists catheter techniques for the treatment of valvular heart disease and circulatory support. He also teaches medical students, medical residents and cardiology fellows clinical research.
ResearchDr. Babaliaros’ research interests are in Valvular and Structural Heart Disease. Specifically, he was a member of the original team that pioneered percutaneous aortic valve replacement in France. His research efforts continue in the field of aortic stenosis, but have also grown to include catheter based therapies for the treatment of mitral regurgitation, aortic insufficiency, and pulmonic valve disease. He is also involved in the current circulatory assist devices that are placed percutaneously for the treatment of cardiogenic shock and high-risk intervention support.
- View publications on PubMed